Symbols / SCPX $0.01 +545.45% Scorpius Holdings, Inc.

Healthcare • Biotechnology • United States • PNK
SCPX Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.

Stock Fundamentals
Scroll to Statements
Market Cap 434.11K Enterprise Value 12.30M Income -25.18M Sales 1.72M Book/sh -0.02 Cash/sh 0.01
Dividend Yield Payout 0.00% Employees 90 IPO P/E Forward P/E -0.00
PEG P/S 0.25 P/B -0.32 P/C EV/EBITDA -0.56 EV/Sales 7.17
Quick Ratio 0.07 Current Ratio 0.10 Debt/Eq LT Debt/Eq EPS (ttm) -4.18 EPS next Y -2.91
EPS Growth Revenue Growth -75.10% Earnings 2024-04-26 ROA -47.94% ROE -3.03% ROIC
Gross Margin 0.00% Oper. Margin -20.57% Profit Margin 0.00% Shs Outstand 61.14M Shs Float 60.81M Short Float 2.25%
Short Ratio 0.56 Short Interest 52W High 0.15 52W Low 0.00 Beta -4.99 Avg Volume 25.39K
Volume 60.81K Target Price Recom None Prev Close $0.00 Price $0.01 Change 545.45%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
$0.01
Latest analyst target
3. DCF / Fair value
$-2.39
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.01
Low
High
Mean

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-05-01 down Brookline Capital Buy → Hold
2023-04-03 down Maxim Group Buy → Hold
2021-03-03 init Cantor Fitzgerald — → Overweight $22
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-05-16 WOLF JEFFREY ALAN J.D. Chief Executive Officer 2,500,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
6.24
-10.75%
6.99
+1789.60%
0.37
0.00
Operating Revenue
6.24
-10.75%
6.99
+1789.60%
0.37
0.00
Cost Of Revenue
3.20
+16.78%
2.74
+3266.75%
0.08
0.00
Reconciled Cost Of Revenue
3.20
+16.78%
2.74
+3266.75%
0.08
0.00
Gross Profit
3.05
-28.44%
4.26
+1373.91%
0.29
0.00
Operating Expense
35.90
-22.45%
46.29
+14.71%
40.35
+29.46%
31.17
Research And Development
14.33
-28.79%
20.12
-0.51%
20.22
+22.90%
16.46
Selling General And Administration
21.57
-17.57%
26.17
+30.00%
20.13
+19.62%
16.83
General And Administrative Expense
21.57
-17.57%
26.17
+30.00%
20.13
+19.62%
16.83
Other Gand A
21.57
-17.57%
26.17
+30.00%
20.13
+19.62%
16.83
Other Operating Expenses
-0.40
+80.96%
-2.11
Total Expenses
39.09
-20.26%
49.03
+21.25%
40.44
+29.72%
31.17
Operating Income
-32.85
+21.84%
-42.03
-4.91%
-40.07
-28.53%
-31.17
Total Operating Income As Reported
-33.60
+20.06%
-42.03
-4.50%
-40.22
-13.56%
-35.42
EBITDA
-26.22
+22.86%
-33.99
+11.16%
-38.26
-25.19%
-30.56
Normalized EBITDA
-25.38
+25.60%
-34.11
+6.32%
-36.41
-42.83%
-25.49
Reconciled Depreciation
7.15
-5.44%
7.57
+140.51%
3.15
+417.66%
0.61
EBIT
-33.37
+19.69%
-41.56
-0.36%
-41.41
-32.84%
-31.17
Total Unusual Items
-0.84
-781.42%
0.12
+106.66%
-1.85
+63.54%
-5.07
Total Unusual Items Excluding Goodwill
-0.84
-781.42%
0.12
+106.66%
-1.85
+63.54%
-5.07
Special Income Charges
-1.31
0.00
+100.00%
-0.16
+96.29%
-4.25
Other Special Charges
0.56
Impairment Of Capital Assets
1.94
0.00
0.00
-100.00%
1.45
Restructuring And Mergern Acquisition
-1.19
0.00
+100.00%
-3.34
-877.33%
0.43
Write Off
0.00
-100.00%
3.50
+47.93%
2.37
Net Income
-32.81
+27.44%
-45.22
-4.10%
-43.43
-23.85%
-35.07
Pretax Income
-34.33
+18.91%
-42.33
-1.79%
-41.59
-17.00%
-35.55
Net Non Operating Interest Income Expense
-0.93
-191.24%
-0.32
-139.72%
0.80
-1.30%
0.82
Interest Expense Non Operating
0.95
+22.70%
0.78
+325.64%
0.18
Net Interest Income
-0.93
-191.24%
-0.32
-139.72%
0.80
-1.30%
0.82
Interest Expense
0.95
+22.70%
0.78
+325.64%
0.18
Interest Income Non Operating
0.02
-95.14%
0.46
-53.69%
0.99
+21.09%
0.82
Interest Income
0.02
-95.14%
0.46
-53.69%
0.99
+21.09%
0.82
Other Income Expense
-0.55
-3095.45%
0.02
+100.78%
-2.33
+55.11%
-5.19
Other Non Operating Income Expenses
0.29
+379.16%
-0.10
+78.28%
-0.48
-291.55%
-0.12
Gain On Sale Of Security
0.47
+282.63%
0.12
+107.28%
-1.69
-106.20%
-0.82
Tax Provision
0.00
+100.00%
-0.57
-164.48%
-0.22
-47.93%
-0.15
Tax Rate For Calcs
0.00
-100.00%
0.00
+159.84%
0.00
+26.42%
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
0.00
+117.30%
-0.01
+53.90%
-0.02
Net Income Including Noncontrolling Interests
-34.33
+26.70%
-46.83
-6.77%
-43.86
-23.90%
-35.40
Net Income From Continuing Operation Net Minority Interest
-32.81
+18.28%
-40.15
+1.96%
-40.95
-16.75%
-35.07
Net Income From Continuing And Discontinued Operation
-32.81
+27.44%
-45.22
-4.10%
-43.43
-23.85%
-35.07
Net Income Continuous Operations
-34.33
+17.80%
-41.76
-0.94%
-41.38
-16.88%
-35.40
Net Income Discontinuous Operations
0.00
+100.00%
-5.07
-103.88%
-2.49
Minority Interests
1.52
-5.95%
1.62
+278.02%
0.43
+29.80%
0.33
Normalized Income
-31.97
+20.61%
-40.27
-2.96%
-39.11
-30.26%
-30.02
Net Income Common Stockholders
-32.81
+27.44%
-45.22
-4.10%
-43.43
-23.85%
-35.07
Diluted EPS
-13.04
+96.25%
-347.50
-2.21%
-340.00
-20.57%
-282.00
Basic EPS
-13.04
+96.25%
-347.50
-2.21%
-340.00
-20.57%
-282.00
Basic Average Shares
2.52
+1833.40%
0.13
+1.63%
0.13
+2.78%
0.12
Diluted Average Shares
2.52
+1833.40%
0.13
+1.63%
0.13
+2.78%
0.12
Diluted NI Availto Com Stockholders
-32.81
+27.44%
-45.22
-4.10%
-43.43
-23.85%
-35.07
Amortization
1.03
0.00
Amortization Of Intangibles Income Statement
1.03
0.00
Depreciation Amortization Depletion Income Statement
1.03
0.00
Depreciation And Amortization In Income Statement
1.03
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
39.18
-23.24%
51.04
-51.11%
104.40
-13.69%
120.96
Current Assets
3.26
-31.50%
4.76
-90.49%
50.05
-49.61%
99.33
Cash Cash Equivalents And Short Term Investments
1.16
-51.36%
2.39
-93.87%
39.03
-59.50%
96.38
Cash And Cash Equivalents
1.03
+455.90%
0.18
-94.21%
3.19
-60.37%
8.05
Other Short Term Investments
0.14
-93.88%
2.21
-93.84%
35.84
-59.43%
88.32
Receivables
0.84
+9.84%
0.76
-52.47%
1.61
+2331.49%
0.07
Accounts Receivable
0.14
-61.76%
0.38
+360.61%
0.08
+23.33%
0.07
Other Receivables
0.70
+478.31%
0.12
-92.12%
1.52
Taxes Receivable
0.60
0.00
Inventory
0.20
-78.15%
0.91
0.00
Prepaid Assets
0.83
+118.82%
0.38
+6.01%
0.36
-85.22%
2.43
Assets Held For Sale Current
0.00
-100.00%
7.93
Other Current Assets
0.23
-27.78%
0.32
-72.04%
1.13
+146.18%
0.46
Total Non Current Assets
35.92
-22.39%
46.28
-14.84%
54.34
+151.24%
21.63
Net PPE
34.34
-22.13%
44.10
+5.93%
41.63
+843.64%
4.41
Gross PPE
37.34
-27.75%
51.68
+15.91%
44.59
+653.70%
5.92
Accumulated Depreciation
-3.00
+60.42%
-7.58
-156.67%
-2.95
-96.42%
-1.50
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.89
-21.54%
1.13
+42.36%
0.79
+424.16%
0.15
Construction In Progress
0.06
+511.02%
0.01
-99.54%
2.05
+563.18%
0.31
Other Properties
35.06
-26.52%
47.72
+21.56%
39.26
+622.61%
5.43
Leases
1.34
-52.76%
2.83
+13.71%
2.49
+10919.50%
0.02
Goodwill And Other Intangible Assets
11.97
+242.04%
3.50
Goodwill
3.30
0.00
Other Intangible Assets
8.67
+147.70%
3.50
Non Current Accounts Receivable
1.10
-36.05%
1.72
1.32
Non Current Prepaid Assets
0.27
+8.10%
0.25
-7.15%
0.27
+31.35%
0.21
Other Non Current Assets
0.20
+0.00%
0.20
-98.37%
12.44
+2.01%
12.19
Total Liabilities Net Minority Interest
37.50
+64.88%
22.74
-28.84%
31.96
+257.99%
8.93
Current Liabilities
24.29
+140.48%
10.10
-44.00%
18.04
+282.09%
4.72
Payables And Accrued Expenses
4.92
-17.72%
5.98
+6.03%
5.64
+95.58%
2.88
Payables
3.23
-22.21%
4.15
-2.47%
4.25
+280.55%
1.12
Accounts Payable
3.23
-21.48%
4.11
-2.46%
4.21
+356.63%
0.92
Other Payable
0.31
-26.47%
0.43
Current Accrued Expenses
1.69
-7.54%
1.83
+32.12%
1.39
-21.53%
1.77
Pensionand Other Post Retirement Benefit Plans Current
0.30
-10.39%
0.33
-32.28%
0.49
+6.97%
0.46
Total Tax Payable
0.00
-100.00%
0.04
-3.00%
0.04
-79.49%
0.20
Income Tax Payable
1.09
0.00
Current Debt And Capital Lease Obligation
17.44
+1120.21%
1.43
+104.45%
0.70
+14.40%
0.61
Current Debt
16.02
Other Current Borrowings
16.02
Current Capital Lease Obligation
1.42
-0.62%
1.43
+104.45%
0.70
+14.40%
0.61
Current Deferred Liabilities
1.64
-30.67%
2.36
+48.78%
1.59
0.00
Current Deferred Revenue
1.64
-30.67%
2.36
+48.78%
1.59
0.00
Other Current Liabilities
0.31
-96.74%
9.62
+1153.93%
0.77
Total Non Current Liabilities Net Minority Interest
13.21
+4.49%
12.64
-9.19%
13.92
+230.95%
4.21
Liabilities Heldfor Sale Non Current
0.00
-100.00%
5.29
Long Term Debt And Capital Lease Obligation
11.11
-11.89%
12.61
+46.67%
8.60
+553.35%
1.32
Long Term Capital Lease Obligation
11.11
-11.89%
12.61
+46.67%
8.60
+553.35%
1.32
Non Current Deferred Liabilities
0.00
-100.00%
0.03
-7.69%
0.03
-87.05%
0.25
Non Current Deferred Revenue
0.00
-100.00%
0.03
-7.69%
0.03
-7.14%
0.04
Non Current Deferred Taxes Liabilities
0.00
-100.00%
0.22
Other Non Current Liabilities
5.29
+101.26%
2.63
Stockholders Equity
6.30
-79.94%
31.40
-57.53%
73.92
-34.64%
113.11
Common Stock Equity
6.30
-79.94%
31.40
-57.53%
73.92
-34.64%
113.11
Capital Stock
0.00
+3811.54%
0.00
-99.49%
0.01
+1.40%
0.01
Common Stock
0.00
+3811.54%
0.00
-99.49%
0.01
+1.40%
0.01
Share Issued
5.08
+3777.49%
0.13
+2.17%
0.13
+0.05%
0.13
Ordinary Shares Number
5.08
+3777.49%
0.13
+2.17%
0.13
+0.05%
0.13
Additional Paid In Capital
293.25
+2.64%
285.72
+0.95%
283.02
+1.48%
278.89
Retained Earnings
-287.18
-12.90%
-254.37
-21.62%
-209.15
-26.21%
-165.72
Gains Losses Not Affecting Retained Earnings
0.22
+358.52%
0.05
-5.87%
0.05
+176.43%
-0.07
Minority Interest
-4.62
-49.00%
-3.10
-108.74%
-1.49
-38.28%
-1.07
Other Equity Adjustments
0.22
+358.52%
0.05
-5.87%
0.05
+176.43%
-0.07
Total Equity Gross Minority Interest
1.68
-94.07%
28.29
-60.94%
72.44
-35.34%
112.03
Total Capitalization
6.30
-79.94%
31.40
-57.53%
73.92
-34.64%
113.11
Working Capital
-21.03
-293.84%
-5.34
-116.68%
32.02
-66.16%
94.61
Invested Capital
22.32
-28.93%
31.40
-57.53%
73.92
-34.64%
113.11
Total Debt
28.55
+103.31%
14.04
+51.01%
9.30
+382.50%
1.93
Net Debt
14.99
Capital Lease Obligations
12.53
-10.75%
14.04
+51.01%
9.30
+382.50%
1.93
Net Tangible Assets
6.30
-79.94%
31.40
-57.53%
73.92
-32.56%
109.61
Tangible Book Value
6.30
-79.94%
31.40
-57.53%
73.92
-32.56%
109.61
Derivative Product Liabilities
2.10
0.00
0.00
-100.00%
0.01
Duefrom Related Parties Current
0.00
-100.00%
0.27
0.00
Duefrom Related Parties Non Current
1.10
-36.05%
1.72
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-26.01
+17.52%
-31.53
-453.17%
-5.70
+85.05%
-38.13
Cash Flow From Continuing Operating Activities
-26.01
+17.52%
-31.53
-453.17%
-5.70
+85.05%
-38.13
Net Income From Continuing Operations
-34.33
+26.70%
-46.83
-6.77%
-43.86
-23.90%
-35.40
Depreciation Amortization Depletion
7.15
-5.44%
7.57
+140.51%
3.15
+417.66%
0.61
Depreciation
7.15
+10.50%
6.47
+206.11%
2.12
+248.05%
0.61
Amortization Cash Flow
0.00
-100.00%
1.09
+5.88%
1.03
0.00
Depreciation And Amortization
7.15
-5.44%
7.57
+140.51%
3.15
+417.66%
0.61
Amortization Of Intangibles
0.00
-100.00%
1.09
+5.88%
1.03
0.00
Other Non Cash Items
-0.77
-15.75%
-0.67
+80.04%
-3.34
-722.54%
0.54
Stock Based Compensation
1.03
-60.67%
2.63
-35.67%
4.09
-33.77%
6.17
Asset Impairment Charge
1.94
-68.47%
6.15
+75.74%
3.50
-8.34%
3.82
Deferred Tax
0.00
+100.00%
-0.57
+82.64%
-3.29
Deferred Income Tax
0.00
+100.00%
-0.57
+82.64%
-3.29
Operating Gains Losses
0.65
+144.57%
-1.47
-13216.25%
-0.01
+51.58%
-0.02
Gain Loss On Investment Securities
-0.47
-0.01
+51.58%
-0.02
Unrealized Gain Loss On Investment Securities
-0.00
+99.19%
-0.12
-107.23%
1.70
+101.94%
0.84
Gain Loss On Sale Of PPE
0.56
0.00
Change In Working Capital
-1.69
-194.68%
1.78
-94.49%
32.36
+320.49%
-14.68
Change In Receivables
0.23
-87.28%
1.83
-92.60%
24.75
+2148.26%
-1.21
Changes In Account Receivables
0.23
+179.30%
-0.29
-1739.41%
-0.02
-114.50%
0.11
Change In Inventory
0.71
+178.15%
-0.91
-115.56%
5.84
0.00
Change In Prepaid Assets
-0.78
-128.26%
2.77
+47083.28%
-0.01
+99.48%
-1.14
Change In Payables And Accrued Expense
-0.92
+54.65%
-2.04
-1277.13%
0.17
-78.41%
0.80
Change In Accrued Expense
-0.04
+97.81%
-1.92
+38.53%
-3.13
-436.50%
0.93
Change In Payable
-0.88
-654.80%
-0.12
-103.54%
3.30
+2699.18%
-0.13
Change In Account Payable
-0.88
-654.80%
-0.12
-103.54%
3.30
+2699.18%
-0.13
Change In Other Working Capital
-0.92
-219.74%
0.77
-51.30%
1.58
+266.28%
-0.95
Change In Other Current Assets
0.00
+100.00%
-0.65
-957.91%
0.08
+100.62%
-12.19
Change In Other Current Liabilities
0.00
+100.00%
-0.05
-409.67%
0.02
Investing Cash Flow
1.21
-96.23%
32.24
+193.28%
10.99
+12.50%
9.77
Cash Flow From Continuing Investing Activities
1.21
-96.23%
32.24
+193.28%
10.99
+12.50%
9.77
Net PPE Purchase And Sale
-0.86
+51.37%
-1.76
+91.06%
-19.73
-935.85%
-1.90
Purchase Of PPE
-0.88
+55.92%
-1.99
+90.13%
-20.12
-956.22%
-1.90
Sale Of PPE
0.02
-92.34%
0.22
-43.11%
0.39
0.00
Capital Expenditure
-0.88
+55.92%
-1.99
+90.13%
-20.12
-956.22%
-1.90
Net Investment Purchase And Sale
2.07
-93.90%
34.00
-33.05%
50.79
+335.00%
11.67
Purchase Of Investment
-0.94
-93.51%
-0.48
+80.32%
-2.46
+96.33%
-66.96
Sale Of Investment
3.01
-91.28%
34.48
-35.23%
53.24
-32.29%
78.64
Net Business Purchase And Sale
0.00
+100.00%
-20.06
0.00
Purchase Of Business
0.00
+100.00%
-22.78
0.00
Gain Loss On Sale Of Business
0.00
+100.00%
-1.47
0.00
Financing Cash Flow
25.64
+386.37%
-8.95
-82.44%
-4.91
-119.25%
25.49
Cash Flow From Continuing Financing Activities
25.64
+386.37%
-8.95
-82.44%
-4.91
-119.25%
25.49
Net Issuance Payments Of Debt
2.33
+190.18%
-2.58
-1015.38%
-0.23
-26.57%
-0.18
Issuance Of Debt
3.23
0.00
0.00
Repayment Of Debt
-0.90
+65.21%
-2.58
-1015.38%
-0.23
-26.57%
-0.18
Long Term Debt Issuance
0.97
0.00
0.00
Long Term Debt Payments
-0.90
+65.21%
-2.58
-1015.38%
-0.23
-26.57%
-0.18
Net Long Term Debt Issuance
0.08
+102.95%
-2.58
-1015.38%
-0.23
-26.57%
-0.18
Short Term Debt Issuance
2.25
0.00
Net Short Term Debt Issuance
2.25
0.00
Net Common Stock Issuance
25.34
+38512.59%
0.07
+9.94%
0.06
-99.77%
26.30
Proceeds From Stock Option Exercised
0.19
0.00
0.00
-100.00%
0.03
Net Other Financing Charges
-2.22
+65.43%
-6.43
-35.88%
-4.74
-619.40%
-0.66
Changes In Cash
0.84
+110.23%
-8.25
-2246.26%
0.38
+113.40%
-2.87
Effect Of Exchange Rate Changes
-0.00
+47.72%
-0.00
+57.09%
-0.00
+62.71%
-0.01
Beginning Cash Position
0.18
-97.81%
8.43
+4.73%
8.05
-26.33%
10.93
End Cash Position
1.03
+455.90%
0.18
-97.81%
8.43
+4.73%
8.05
Free Cash Flow
-26.88
+19.80%
-33.52
-29.82%
-25.82
+35.51%
-40.03
Common Stock Issuance
25.34
+38512.59%
0.07
+9.94%
0.06
-99.77%
26.30
Issuance Of Capital Stock
25.34
+38512.59%
0.07
+9.94%
0.06
-99.77%
26.30
Sale Of Business
0.00
-100.00%
2.72
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category